Thursday Apr 10
PuraMed BioScience to Develop Cannabinoid-Based Medicine
PuraMed BioScience announced today that the company is moving forward with the development of first cannabinoid-based formulation that targets the mental health market by focusing on anxiety and depression.
Trending on the Topix Network
Thu Apr 03, 2014
3 New Treatments Offer Hope for Migraine Sufferers
The first is Cefaly, a headband-like device that runs on a battery and sits across the forehead and over the ears.
Tweeters share their migraine pain in real time
Humans have long understood commiseration to be cathartic. That's why many take to social media to share the specifics of their battles with migraine pain.
At its heart, autism is a disorder that affects human interactions. Families and caregivers are finding new ways to connect with children who have autism.
Mon Mar 31, 2014
There are actions people can take that can help maintain the ability to process and understand speech when communicating with others.
Fri Mar 28, 2014
FDA Agrees to Review Drug - "Device Combo for Migraine
The FDA has accepted a new drug application for AVP-825, an investigational drug-device combination product for the acute treatment of migraine.
If you've ever made a decision not to eat a certain food because it was bad for you, then you're like most Americans who are increasingly more health-conscious.
Wed Mar 26, 2014
Avanir Pharmaceuticals Announces Acceptance of New Drug...
Avanir Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has accepted the company's New Drug Application of AVP-825, its innovative Breath Powereda investigational drug-device combination product for the acute treatment of migraine.
Tue Mar 25, 2014
Investor's Business Daily
Depomed A 'Turtle' Gaining In Specialty Pharma Race
But as CEO James Schoeneck says, it has only just begun to realize its potential.
Mid Rivers Newsmagazine Front Page
Health Capsules: Cosmetic surgeries top 15 million
The number of cosmetic surgeries performed last year in the U.S. topped 15 million, marking the fourth consecutive year of growth for the plastic surgery industry.
Transdermal Patch Delivery Technologies Will Create New Blockbuster Drugs
The transdermal patch has long promised convenient, low-cost, controlled drug delivery.
One of the most prevalent and disabling conditions worldwide, the impact of headaches and migraine is undeniable.
Sun Mar 23, 2014
Use of mood-stabilizing drug linked with reduced risk of developing head and neck cancer
A new study indicates that a commonly used mood stabilizing drug may help prevent head and neck cancer.
Detroit Free Press
Many brain scans unnecessary, study finds
Passing headache or deadly tumor? For peace of mind, 1 in 8 headache and migraine sufferers undergo costly brain scans each year that are usually unnecessary and potentially harmful, according to a new study.
Wed Mar 19, 2014
Migraine Headache Treatment: Cefaly Headband
Do you suffer from migraine headaches? If so, you know how frustrating it can be to find a treatment that works.
Bothell biotech firm Alder plans $115M IPO
Alder Biopharmaceuticals of Bothell has joined an industrywide rush to go public, filing plans Wedensday for an initial public offering to raise up to $115 million.
Tue Mar 18, 2014
Medical News Today
$1 billion a year is spent on brain scans for headache sufferers
Guidelines warn doctors against using brain scans for routine headache and migraine cases.